Age-related macular degeneration and the aging eye
Rita Ehrlich1, Alon Harris1, Nisha S Kheradiya1, Diana M Winston1, Thomas A Ciulla3, Barbara Wirostko21Indiana University School of Medicine, Department of Ophthalmology, Indianapolis, IN, USA; 2Stony Brook University Medical Center Research Way, Department of Ophthalmology, Stony Brook, NY, USA; 3R...
Guardado en:
Autores principales: | Rita Ehrlich, Alon Harris, Nisha S Kheradiya, Diana M Winston, Thomas A Ciulla, Barbara Wirostko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0ab76c20e074755b0639536ea85d93a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration [Corrigendum]
por: Michalska-Małecka K, et al.
Publicado: (2016) -
Repository of proposed pathways and protein–protein interaction networks in age-related macular degeneration
por: Fran M. Pool, et al.
Publicado: (2020) -
Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
por: Robyn H Guymer, et al.
Publicado: (2008) -
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
por: Dimitrios A Karagiannis, et al.
Publicado: (2009) -
Recent developments in age-related macular degeneration: a review
por: Al-Zamil WM, et al.
Publicado: (2017)